HepQuant SHUNT® Liver Diagnostic Test
Hepquant, LLC · Test for Esophageal Varices · Clinical Chemistry
Open FDA's page for this record- PMA number
- P220016
- Applicant
- Hepquant, LLC
- Street 1
- 12635 E. Montview Blvd., Suite 175l1
- City
- Aurora
- State
- CO
- Zip
- 80045
- Generic name
- Test for Esophageal Varices
- Trade name
- HepQuant SHUNT® Liver Diagnostic Test
- Product code
- SIO
- Advisory committee
- CH
- Advisory committee description
- Clinical Chemistry
- Expedited review flag
- N
- Date received
- 2022-09-14
- Decision date
- 2026-06-18
- Docket number
- FDA-6931
- Fed reg notice date
- 2026-06-23
- Decision code
- APPR
- Ao statement
Approval for HepQuant SHUNT® Liver Diagnostic TestThe HepQuant SHUNT® Liver Diagnostic Test is designed for the quantitative detection of 13C-cholate and d4-cholate in human serum from blood samples collected after the intravenous administration of 13C-cholate and the oral ingestion of d4-cholate. The assay generates a Disease Severity Index (DSI) score from the clearance of 13C-cholate and d4-cholate. Sample analysis is conducted by the HepQuant Analytical Test Laboratory.A DSI score below the validated threshold can be used in patients with compensated cirrhosis (Child Pugh Class A), age 22 years or older, undergoing screening or surveillance for esophageal varices to identify those patients unlikely to have large esophageal varices. The DSI score aids in identifying patients unlikely to require esophagogastroduodenoscopy (EGD) at the time of testing.The HepQuant SHUNT® Liver Diagnostic Test is not a stand-alone test and should be used in conjunction with other clinical and laboratory findings.
- Harmonized identifiers (openFDA)
- Device name
- Test For Esophageal Varices
- Medical specialty description
- Unknown
- Device class
- 3
- Registration number
- 3014680149
- FEI number
- 3014680149
